Indomethacin administered early in the postnatal period results in reduced glomerular number in the adult rat

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 10, 2014, Pages F1105-F1110

  Kent, A L ^a,c   Koina, M E ^a   Gubhaju, L ^b   Cullen McEwen, L A ^b   Bertram, J F ^b   Lynnhtun, J ^a   Shadbolt, B ^a,c   Falk, M C ^a,c   Dahlstrom, J E ^a,c  

^a CANBERRA HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c The Australian National University   (Australia)

Author keywords

Fetus; Glomerular number; Ibuprofen; Indomethacin; Kidney; Premature neonate

Indexed keywords

IBUPROFEN; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; UTERUS SPASMOLYTIC AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; KIDNEY; KIDNEY DEVELOPMENT; MALE; MICROSCOPY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; STEREOLOGY; ANIMAL; BODY WEIGHT; DRUG EFFECTS; EMBRYOLOGY; NEWBORN; PREGNANCY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CYCLOOXYGENASE INHIBITORS; FEMALE; IBUPROFEN; INDOMETHACIN; KIDNEY GLOMERULUS; PREGNANCY; RATS, SPRAGUE-DAWLEY; TOCOLYTIC AGENTS;

EID: 84925202852     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00328.2014     Document Type: Article

References (61)

1. Abrahamson DR. Glomerulogenesis in the developing kidney. Semin Nephrol 11: 375-389, 1991.
2. Akima S, Kent A, Reynolds GJ, Gallagher M, Falk MC. Indomethacin and renal impairment in neonates. Pediatr Nephrol 19: 490-493, 2004.
3. Akinola O, Norohna C, Oremosu A, Kusemiju O, Okanlawon A. The effect of the cyclooxygenase blockers, ibuprofen on the development of glomeruli in Sprague-Dawley rats. Niger Postgrad Med J 10: 46-50, 2003.
4. Artinano M, Etheridge WB, Stroehlein KB, Barcenas CG. Progression of minimal-change glomerulopathy to focal glomerulosclerosis in a patient with feno-profen nephropathy. Am J Nephrol 6: 353-357, 1986.
5. Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE. Human nephron number: implications for health and disease. Pediatr Nephrol 26: 1529-1533, 2011.
6. Bertram JF. Analyzing renal glomeruli with new stereology. Int Rev Cytol 161: 111-172, 1995.
7. Black MJ, Wang Y, Bertram JF. Nephron endowment and renal filtration surface area in young spontaneously hypertensive rats. Kidney Blood Press Res 25: 20-26, 2002.
8. Bolisetty S, Patole S, Koh G, Stalewski H, Whitehall J. Neonatal acute haemorrhagic gastritis and antenatal exposure to indomethacin for tocolysis. ANZ J Surg 71: 122-123, 2001.
9. Bouayad A, Hou X, Varma DR, Clyman RI, Fouron JC, Chemtob S. Cyclooxygenase isoforms and prostaglandin E2 receptors in the ductus arteriosus. Curr Ther Res 63: 669-681, 2002.
10. Brenner BM, Chertow GM. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23: 171-175, 1994.
11. Butler-O'Hara M, D'Angio CT. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labour. J Perinatol 22: 541-546, 2002.
12. Coceani F, Barogi S, Brizzi F, Ackerley C, Seidlitz E, Kelsey L, Ballou LR, Baragatti B. Cyclooxygenase isoenzymes and patency of ductus arteriosus. Prostaglandins Leukot Essent Fatty Acids 72: 71-77, 2005.
13. Cullen L, Young R, Bertram J. Studies on the effects of gentamicin on rat metanephric development in vitro. Nephrology 5: 115-123, 2000.
14. Dang D, Wang D, Zhang C, Zhou W, Zhou Q, Wu H. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLos One 11: e77888, 2013.
15. Ellison RC, Peckham GJ, Lang P, Talner NS, Lerer TJ, Lin L, Dooley KJ, Nadas AS. Evaluation of the preterm infant for patent ductus arteriosus. Pediatrics 71: 364-372, 1983.
16. thConference on Pediatric Research, edited by Heymann M, Rudolph A. Columbus, OH: Ross Laboratories, 1978, p. 63-69.
17. Giapros V, Andronikou S, Cholevas V, Papadopoulou Z. Renal function and effect of aminoglycoside therapy during the first ten days of life. Pediatr Nephrol 18: 46-52, 2003.
18. Gilbert T, Gaonach S, Moreau E, Merlet-Benichou C. Defect of nephrogenesis induced by gentamicin in rat metanephric organ culture. Lab Invest 70: 656-666, 1994.
19. Gilbert T, Lelievre-Pegorier M, Merlet-Benichou C. Immediate and long-term renal effects of fetal exposure to gentamicin. Pediatr Nephrol 4: 445-450, 1990.
20. Gilbert T, Lelievre-Pegorier M, Malienou R, Meulemans A, Merlet- Benichou C. Effects of prenatal and postnatal exposure to gentamicin on renal differentiation in the rat. Toxicology 43: 301-313, 1987.
21. Goldenberg RL, Davis RO, Baker RC. Indomethacin induced oligohydramnios. Am J Obstet Gynecol 113: 738-743, 1989.
22. Gournay V. The ductus arteriosus: physiology, regulation, and functional and congenital anomalies. Arch Cardiovasc Dis 104: 578-585, 2011.
23. Grcevska L, Polenakovic M, Ferluga S, Vizjak A, Stavric G. Membranous nephropathy with severe tubulointerstitial and vascular changes in a patient with psoriatic arthritis treated with nonsteroidal anti-inflammatory drugs. Clin Nephrol 39: 250-253, 1993.
24. Gubhaju L, Sutherland MR, Yoder BA, Zulli A, Bertram JF, Black MJ. Is nephrogenesis affected by preterm birth? Studies in a nonhuman primate model. Am J Physiol Renal Physiol 297: F1668-F1677, 2009.
25. Gubhaju L, Sutherland MR, Black MJ. Preterm birth and the kidney: implications for long-term renal health. Reprod Sci 18: 322-333, 2011.
26. Hasan J, Beharry KD, Gharraee Z, Stavitsky Y, Abad-Santos P, Abad-Santos M, Aranda JV, Modanlou HD. Early postnatal ibuprofen and indomethacin effects in suckling and weanling rat kidneys. Prostaglandins Other Lipid Mediat 85: 81-88, 2008.
27. Horster MF, Braun GS, Huber SM. Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev 79: 1157-1191, 1999.
28. Hoy WE, Hughson MD, Singh GR, Douglas-Denton R, Bertram JF. Reduced nephron number and glomerulomegaly in Australian Aborigines: a group at high risk for renal disease and hypertension. Kidney Int 70: 104-110, 2006.
29. Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE. Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int 69: 671-678, 2006.
30. Keller G, Zimmer G, Mall G, Ritz E, Amann K. Nephron number in patients with primary hypertension. N Engl J Med 348: 101-108, 2003.
31. Kent AL, Brown L, Broom M, Broomfield A, Dahlstrom JE. Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury. Pediatr Nephrol 27: 1111-1117, 2012.
32. Kent AL, Maxwell LE, Koina ME, Falk MC, Willenborg D, Dahlstrom JE. Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model. Pediatr Res 62: 307-312, 2007.
33. Kleinknecht D. Diseases of the kidney caused by nonsteroidal antiinflammatory drugs. In: Analgesic and NSAID-Induced-Kidney Disease, edited by Stewart JH. Oxford, UK: Oxford University Press, 1993, p. 160.
34. Komhoff M, Wang JL, Cheng HF, Langenbach R, McKanna JA, Harris RC, Breyer MD. Cyclooygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. Kidney Int 57: 414- 422, 2000.
35. Langhendries JP, Battisti O, Bertrand J. Aminoglycoside nephrotoxicity and urinary excretion of N-acetyl-beta-D-glucosaminidase. Biol Neonate 53: 253-259, 1988.
36. Lasaitiene D, Chen Y, Guron G, Marcussen N, Tarkowski A, Telemo E, Friberg P. Perturbed medullary tubulogenesis in neonatal rat exposed to renin-angiotensin system inhibition. Nephrol Dial Transplant 18: 2534-2541, 2003.
37. Luyckx VA, Bertram JF, Brenner BM, Fall C, Hoy WE, Ozanne SE, Vikse BE. Effect of fetal and child health on kidney development and long-term risk of hypertension and kidney disease. Lancet 382: 273-283, 2013.
38. Mallie JP, Gerard H, Gerard A. In-utero gentamicin-induced nephrotoxicity in rats. Pediatr Pharmacol (New York) 5: 229-239, 1986.
39. Nadir E, Kassem E, Foldi S, Hochberg A, Feldman M. Paracetamol treatment of patent ductus arteriosus in preterm infants. J Perinatol 34: 748-749, 2014.
40. Nagai J, Takano M. Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet 19: 159-170, 2004.
41. Narayanan M, Cooper B, Weiss H, Clyman RI. Prophylactic indomethacin: factors determining permanent ductus closure. J Pediatr 136: 330- 337, 2000.
42. Naruse K, Fujieda M, Miyazaki E, Hayashi Y, Toi M, Fukui T, Kuroda N, Hiroi M, Kurashige T, Enzan H. An immunohistochemical study of developing glomeruli in human fetal kidneys. Kidney Int 57: 1836-1846, 2000.
43. Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T. In utero and in vitro exposure to beta-lactams impair kidney development in the rat. J Am Soc Nephrol 11: 874-884, 2000.
44. Oncel MY, Yurttutan S, Erdeve O, Uras N, Altug N, Oguz SS, Canpolat FE, Dilmen U. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 164: 510-514, 2014.
45. Pezzati M, Vargi V, Biagotti R, Bertini G, Cianciulli D, Rubatelli FF. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135: 733-738, 1999.
46. Pirani CL, Valeri A, D'Agati V, Appel GB. Renal toxicity of nonsteroidal anti-inflammatory drugs. Contrib Nephrol 55: 159-175, 1987.
47. Radford MG, Jr., Holley KE, Grande JP, Larson TS, Wagnoer RD, Donadio JV, McCarthy JT. Reversible membranous nephropathy associated with the use of nonsteroidal anti-inflammatory drugs. JAMA 276: 466-469, 1996.
48. Rodriguez MM, Gomez AH, Abitbol CL, Chandar JJ, Duara S, Zilleruelo GE. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 7: 17-25, 2004.
49. Skov K, Nyengaard JR, Korsgaard N, Mulvany MK. Number and size of renal glomeruli in spontaneously hypertensive rats. J Hypertens 12: 1373-1376, 1994.
50. Sodini D, Baragatti B, Barogi S, Laubach VE, Coceani F. Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse. Br J Pharmacol 153: 1631-1640, 2008.
51. Stelloh C, Allen KP, Mattson DL, Lerch-Gaggl A, Reddy S, El- Meanawy A. Prematurity in mice leads to reduction in nephron number, hypertension, and proteinuria. Transl Res 159: 80-89, 2012.
52. Sutherland MR, Gubhaju L, Moore L, Kent AL, Dahlstrom JE, Horen RS, Hoy W, Bertram JF, Black MJ. Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 22: 1365-1374, 2011.
53. Sutherland MR, Yoder BA, McCurnin D, Seider S, Gubhaju L, Clyman RI, Black MJ. Effects of ibuprofen treatment on the developing preterm baboon kidney. Am J Physiol Renal Physiol 302: F1286-F1292, 2012.
54. Tarcan A, Gurakan B, Yildrim S, Ozkiraz S, Bilezikci B. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure. J Perinat Med 32: 98-99, 2004.
55. Terrin G, Conte F, Scipione A, Bacchio E, Conti MG, Ferro R, Ventriglia F, De Curtis M. Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm nenonates. Ital J Pediatr 40: 21-24, 2014.
56. Toyoshima K, Takeda A, Imamura S, Nakanishi T, Momma K. Constriction of the ductus arteriosus by selective inhibition of cycloxygenase- 1 and -2 in near-term and preterm fetal rats. Prostaglandins Other Lipid Med 79: 34-42, 2006.
57. Tugay S, Bircan Z, Caglayan C, Arisoy AE, Gokalp AS. Acute effects of gentamicin on glomerular and tubular functions in preterm neonates. Pediatr Nephrol 21: 1389-1392, 2006.
58. Vanhaesebrouck P, Thiery M, Leroy JG, Govaert D, de Praeter G, Coppens M, Cuvelier C, Dhont M. Oligohydramnios renal insufficiency and ileal perforation in preterm infants after intrauterine exposure to indomethacin. J Pediatr 113: 738-743, 1988.
59. Van Overmeire B, Van deBroek H, VanLaer P, Weyler J, Vanbaesebrouck P. Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr 138: 205-211, 2001.
60. Vieux R, Fresson J, Guillemin F, Hascoet JM. Perinatal drug exposure and renal function in very preterm infants. Arch Dis Child Fetal Neonatal Ed 96: F290-F295, 2011.
61. Zumrutdal AO, Turan C, Cetin F, Adanali S. Relationship between renal size and hypertension in patients with chronic renal failure. Nephron 90: 145-147, 2002.